Duopharma Biotech Bhd
KLSE:DPHARMA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Duopharma Biotech Bhd
Total Current Liabilities
Duopharma Biotech Bhd
Total Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
D
|
Duopharma Biotech Bhd
KLSE:DPHARMA
|
Total Current Liabilities
314m
|
CAGR 3-Years
6%
|
CAGR 5-Years
16%
|
CAGR 10-Years
15%
|
|
|
P
|
PeterLabs Holdings Bhd
KLSE:PLABS
|
Total Current Liabilities
21.6m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
10%
|
CAGR 10-Years
9%
|
|
|
A
|
Apex Healthcare Bhd
KLSE:AHEALTH
|
Total Current Liabilities
159.7m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
5%
|
|
|
R
|
Rhone Ma Holdings Bhd
KLSE:RHONEMA
|
Total Current Liabilities
52.2m
|
CAGR 3-Years
16%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
|
Y
|
YSP Southeast Asia Holding Bhd
KLSE:YSPSAH
|
Total Current Liabilities
70.9m
|
CAGR 3-Years
3%
|
CAGR 5-Years
2%
|
CAGR 10-Years
6%
|
|
|
K
|
Kotra Industries Bhd
KLSE:KOTRA
|
Total Current Liabilities
54m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
8%
|
CAGR 10-Years
-1%
|
|
Duopharma Biotech Bhd
Glance View
Duopharma Biotech Bhd.is an investment holding company, which engages in the manufacturing and distribution of pharmaceutical products. The company is headquartered in Klang, Selangor. The company went IPO on 2002-07-18. The Company, through its subsidiaries is engaged in manufacturing, distribution, importing and exporting of pharmaceutical products and medicines. The firm also engaged in research and development of pharmaceutical products. Its subsidiaries include Duopharma (M) Sendirian Berhad, Duopharma Manufacturing (Bangi) Sdn. Bhd., Duopharma Marketing Sdn. Bhd., Duopharma Consumer Healthcare Sdn. Bhd., Duopharma HAPI Sdn. Bhd., Duopharma Innovation Sdn. Bhd., Unique Pharmacy (Penang) Sdn. Bhd., Sentosa Pharmacy Sdn. Bhd., Duopharma Manufacturing (Glenmarie) Sdn. Bhd., Negeri Pharmacy Sdn. Bhd., Duopharma (Singapore) Pte. Ltd. and DB (Philippines), Inc.
See Also
What is Duopharma Biotech Bhd's Total Current Liabilities?
Total Current Liabilities
314m
MYR
Based on the financial report for Dec 31, 2025, Duopharma Biotech Bhd's Total Current Liabilities amounts to 314m MYR.
What is Duopharma Biotech Bhd's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
15%
Over the last year, the Total Current Liabilities growth was 76%. The average annual Total Current Liabilities growth rates for Duopharma Biotech Bhd have been 6% over the past three years , 16% over the past five years , and 15% over the past ten years .
